Total Payments
$4,132
2024 Payments
$685.00
Companies
33
Transactions
259
Medicare Patients
7,678
Medicare Billing
$796,427
Payment Breakdown by Category
Food & Beverage$3,944 (95.4%)
Other$174.24 (4.2%)
Education$13.89 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,944 | 257 | 95.4% |
| Debt forgiveness | $174.24 | 1 | 4.2% |
| Education | $13.89 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $608.17 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $416.21 | 26 | $0 (2024) |
| Amgen Inc. | $395.33 | 26 | $0 (2024) |
| PFIZER INC. | $289.89 | 21 | $0 (2024) |
| Novo Nordisk Inc | $234.42 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $233.28 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $217.58 | 16 | $0 (2022) |
| Merck Sharp & Dohme LLC | $193.49 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $191.35 | 11 | $0 (2024) |
| Baxter Healthcare | $174.24 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $685.00 | 37 | GlaxoSmithKline, LLC. ($88.23) |
| 2023 | $567.18 | 32 | AbbVie Inc. ($130.49) |
| 2022 | $707.60 | 40 | ABBVIE INC. ($206.86) |
| 2021 | $562.05 | 42 | AbbVie Inc. ($172.88) |
| 2020 | $254.62 | 16 | GlaxoSmithKline, LLC. ($47.85) |
| 2019 | $253.22 | 17 | Amgen Inc. ($58.41) |
| 2018 | $382.41 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($83.95) |
| 2017 | $719.93 | 51 | Merck Sharp & Dohme Corporation ($103.35) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.09 | General |
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Gastroenterology | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: PAIN | ||||||
| 09/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Oncology | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: DIABETES | ||||||
| 05/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Oncology | ||||||
| 05/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,737 | 3,073 | $401,289 | $200,714 |
| 2022 | 16 | 1,829 | 3,029 | $348,883 | $185,156 |
| 2021 | 22 | 1,918 | 2,980 | $354,769 | $193,867 |
| 2020 | 27 | 2,194 | 3,694 | $468,993 | $216,690 |
Total Patients
7,678
Total Services
12,776
Medicare Billing
$796,427
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 393 | 393 | $84,288 | $48,613 | 57.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 408 | 783 | $96,580 | $46,661 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 363 | 569 | $97,845 | $42,349 | 43.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 247 | 888 | $75,352 | $40,807 | 54.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 28 | $10,942 | $5,966 | 54.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $12,904 | $5,316 | 41.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 28 | $7,672 | $4,256 | 55.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 55 | 98 | $5,491 | $3,399 | 61.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $7,768 | $2,648 | 34.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 21 | 21 | $664.44 | $271.13 | 40.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 43 | 55 | $705.00 | $187.55 | 26.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $584.32 | $180.69 | 30.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 70 | $492.50 | $59.57 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 451 | 790 | $121,660 | $60,286 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 416 | 669 | $72,274 | $37,694 | 52.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 293 | 293 | $76,180 | $37,212 | 48.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 217 | 684 | $37,275 | $27,178 | 72.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 71 | 71 | $14,129 | $5,762 | 40.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 71 | 149 | $6,556 | $5,073 | 77.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 21 | 22 | $5,346 | $3,506 | 65.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $5,852 | $2,150 | 36.7% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 53 | 53 | $2,120 | $2,027 | 95.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $1,960 | $1,916 | 97.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $1,120 | $798.58 | 71.3% |
| 0012A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | Office | 2022 | 14 | 14 | $560.00 | $530.76 | 94.8% |
About Dr. Robert Allen, M.D
Dr. Robert Allen, M.D is a Family Medicine healthcare provider based in Gold Canyon, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639195977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Allen, M.D has received a total of $4,132 in payments from pharmaceutical and medical device companies, with $685.00 received in 2024. These payments were reported across 259 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,944).
As a Medicare-enrolled provider, Allen has provided services to 7,678 Medicare beneficiaries, totaling 12,776 services with total Medicare billing of $796,427. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Gold Canyon, AZ
- Active Since 07/13/2006
- Last Updated 03/28/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1639195977
Products in Payments
- TRELEGY ELLIPTA (Drug) $351.94
- UBRELVY (Drug) $297.28
- EVENITY (Biological) $189.42
- XARELTO (Drug) $182.27
- JARDIANCE (Drug) $145.15
- FARXIGA (Drug) $132.87
- Prolia (Biological) $132.83
- QULIPTA (Drug) $115.94
- SYNTHROID (Drug) $114.80
- Ozempic (Drug) $113.08
- Amitiza (Drug) $106.76
- JANUVIA (Drug) $99.02
- LYRICA (Drug) $93.33
- Cologuard Collection Kit (Device) $88.75
- BREZTRI (Drug) $73.18
- MYRBETRIQ (Drug) $71.63
- ENTRESTO (Drug) $67.09
- CHANTIX (Drug) $66.57
- Victoza (Drug) $64.19
- MOUNJARO (Drug) $62.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.